Clinical Trials Directory

Trials / Terminated

TerminatedNCT01803880

Mechanical vs. Radiofrequency-Based Debridement in the Treatment of Articular Cartilage Lesions

A Prospective, Double Blinded, Multicenter, Randomized, Controlled Trial to Evaluate Mechanical Debridement vs. Radiofrequency-Based Debridement in the Treatment of Articular Cartilage Lesions

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
148 (actual)
Sponsor
Smith & Nephew, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate changes in clinical and imaging outcomes following arthroscopic treatment of a single medial femoral chondral lesion plus partial medial meniscectomy by Radiofrequency-Based debridement or Mechanical Debridement in subjects ≥ eighteen (18) years of age.

Detailed description

This is a non-inferiority, prospective, double blinded, multi-center, randomized, controlled, adaptive study design with enrollment of 82 randomized subjects at up to 13 study sites. Study duration will be until the last subject enrolled reaches 104 weeks post-operative. The study will be comprised of two parts: Part I: Part I will require all Investigators perform 1 to 3 procedures using the Quantum 2 Controller plus Paragon T2 ICW Wand or the WEREWOLF Controller plus FLOW 50 Wand. Investigators must be qualified by training to perform procedures prior to use of either study device. This purpose of Part I will be to minimize variability with the recommended directions for use established in the instructions for use (IFU). Part I subjects will be followed per protocol follow-up requirements, and will be included in the safety population only. These subjects will be additive (to the safety population) to the 82 randomized subjects planned as part of the primary evaluation in Part II. Part II: Part II will consist of 82 randomized subjects. Each Investigator may initiate enrollment of subjects in this part of the study following completion of Part I requirements. The Part II study implements a randomized adaptive study design, whereby an interim analysis will be conducted for sample size re-assessment. There is no intention of reducing the sample size as a result of this interim analysis; however, the sample size may be increased to either establish the non-inferiority and/or may be increased sufficiently to establish superiority depending on the results of the interim analysis.

Conditions

Interventions

TypeNameDescription
DEVICEMechanical Debridementmechanical shaver that removes areas of damaged tissue
DEVICERF-Based DebridementElectrical energy that removes areas of damaged tissue (Coblation®)

Timeline

Start date
2013-03-08
Primary completion
2017-05-04
Completion
2017-07-21
First posted
2013-03-04
Last updated
2019-03-28
Results posted
2019-03-28

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01803880. Inclusion in this directory is not an endorsement.